MeMed’s sepsis test receives FDA breakthrough device status
The test builds upon the MeMed BV test, which assists clinicians in distinguishing between bacterial and viral infections.
The test builds upon the MeMed BV test, which assists clinicians in distinguishing between bacterial and viral infections.
The MHRA is looking at five technologies in its AI Airlock pilot scheme, looking to inform its regulatory approach.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
SyntheticMR looks to expand AI and cloud capabilities with Combinostics acquisition
Navigating privacy, regulation, and the political divide in AI healthcare
Healthtech collaborations are shaping diabetes management in Singapore, says analyst
RFK’s regulatory plans could overburden small manufacturers, says analyst